Oxycodon/Naloxon Heumann (Naloxone Hydrochloride Dihydrate, Oxycodone Hydrochloride Ph. Eur.)

Oxycodone/Naloxone is used for pain management within the opioid pathway, providing relief for several conditions:

• Chronic non‑cancer pain: Improves pain control when combined with opioid therapy.
• Cancer‑related pain: Enhances analgesia while reducing abuse risk.
• Post‑operative surgical pain: Provides effective post‑operative analgesia.
• Acute musculoskeletal pain: Offers short‑term pain relief after injury.
• Severe pain episodes in palliative care: Delivers strong analgesia for end‑of‑life comfort.

• Oxycodone activates μ‑opioid receptors in the central nervous system, producing analgesia and a sense of well‑being. Naloxone has a low oral bioavailability but, if the tablet is tampered with, it is released systemically to competitively block μ‑receptor activation, thereby deterring opioid misuse while preserving analgesic effect when taken as intended.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Constipation: reduced bowel motility.
• Drowsiness: sedation or fatigue.
• Dizziness: light‑headed sensation.
• Dry mouth: reduced salivation.
• Headache: tension‑type or throbbing pain.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that may be life‑threatening.
• Severe hypotension: marked drop in blood pressure.
• Opioid dependence: risk of physical dependence with prolonged use.
• Hepatic impairment: liver function abnormalities.
• Allergic reactions: rash, itching, or anaphylaxis.
• Seizures: rare neurologic events.

When prescribing Oxycodone/Naloxone, clinicians should consider several safety measures:

• Assess pain severity: confirm that opioid therapy is appropriate for the patient’s level of pain.
• Review medical history: check for respiratory disorders, liver disease, or prior substance abuse.
• Monitor for sedation: advise patients not to operate machinery or drive while sedated.
• Adjust dose cautiously: titrate based on response and tolerability, especially in the elderly.
• Educate on misuse risk: inform patients about the purpose of naloxone in the formulation.
• Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Oxycodone/Naloxone interacts with several drug classes; careful management is required:

Major Interactions (Avoid)

• CNS depressants: concurrent use with benzodiazepines or barbiturates can cause profound respiratory depression.
• MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.
• CYP3A4 inhibitors: strong inhibitors (e.g., ketoconazole) increase oxy‑opioid levels, raising overdose risk.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors: drugs like fluoxetine can reduce oxycodone metabolism, altering analgesic effect.
• Diuretics: may enhance hypotensive effects when combined with opioid‑induced vasodilation.
• Anticholinergics: can worsen constipation, a common opioid side effect.